MedTrace Logo

Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers

NCT02391909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 855

Last updated 2023-07-07

No results posted yet for this study

Summary

This is a multicenter (at travel clinics), phase 4 observational prospective cohort study in healthy adult male and female travelers for whom typhoid vaccination with Vivotif is recommended, as per standard practice.

Conditions

  • Typhoid Fever

Interventions

BIOLOGICAL

Vivotif

Sponsors & Collaborators

  • Emergent BioSolutions

    collaborator INDUSTRY

  • Bavarian Nordic

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-26
Primary Completion
2016-10-06
Completion
2017-02-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391909 on ClinicalTrials.gov